Global Ophthalmic Implant Market Outlook and Forecasts 2022-2027: Rise of Artificial Intelligence to Detect Diabetic Retinopathy and Increased Use of Robotic Surgical Assistants for Eye Surgery – Tips & Results

DUBLIN, April 20, 2022–(BUSINESS WIRE)–The Ophthalmic Implants Market – Global Outlook & Forecast 2022-2027 report has been added Offer.

The ophthalmic implant market size is expected to grow at a CAGR of 6.5%.

Intraocular lenses are expected to register the highest incremental growth and glaucoma implants the highest absolute growth during the forecast period. Rising cases of presbyopia, myopia, blindness, cataract surgery and farsightedness are expected to boost demand for the global eye implant market.

Other important reasons behind the growth of the market are the increasing awareness of comprehensive ophthalmic services, the increase in the geriatric population and the inclusion of ophthalmic services in the insurance system. The total number of patients undergoing cataract surgery has more than tripled in a decade, a key factor that has impacted intraocular lens industry players.

Hospitals are expected to witness the highest incremental growth over the forecast period. The hospital segment is the dominant segment in the ophthalmic implant market. Glaucoma drain implantation is performed in an outpatient surgery center or hospital.

The increasing aging of the population and rising awareness in the North American region is expected to drive the ophthalmic implant market size in the region.


Advances in ophthalmic diagnostic technology have led to broader product acceptance. The easy accessibility of online tools has enlightened the public about different treatment options and will help the market to grow. The increasing acceptance of advanced ocular devices such as artificial eyes and glaucoma devices has opened up the potential for companies operating in the market.

The increasing number of regulatory approvals for corneal implants will help large companies to generate significant revenue from the ocular implant market in the years to come.

The emergence of various advanced intraocular lenses and increasing competition among manufacturers to develop better lenses, as well as an increase in investment in eye research institutes by governmental and non-governmental organizations are expected to boost the market growth.


  • Growing advances in ophthalmic diagnostic technology

  • Increasing acceptance of advanced eyepiece devices

  • Increase in the number of cases of eye diseases

  • Raising awareness of the diagnosis and treatment of eye diseases

  • Product launches and approvals to increase market share

  • In May 2020, the launch of the presbyopia-correcting intraocular lens (IOL) LuxSmart and its monofocal version LuxGood was announced. Both come with pre-installed delivery systems and Pure Refractive Optics (PRO) technology.

  • In January 2021, the AcrySof IQ Vivity IOL (Vivity), the extended depth of field (IOL) non-diffractive intraocular lens, was launched in the United States. Vivity is used in the AcrySof IQ IOL.

key provider


  • Johnson&Johnson

  • Bausch & Lomb

Other prominent providers

  • second look

  • microtechnical solutions

  • Gulden Ophthalmic

  • AJL Ophthalmic SA

  • EyeD Pharma

  • care group

  • F. Ad. Mueller Sons GmbH & Co. KG

  • Hoya Corporation

  • Morcher GmbH

  • Ophtec B.V

  • BVI

  • Rayner Intraocular Lenses Limited

  • Glaukos Corporation

  • CorNeat Vision

  • humanoptics

  • omni lens


  • InnFocus



  • SMR Ophthalmology PVT. GMBH

  • Labtician Ophthalmics, Inc

  • Divine Meditech

  • innolens

  • iSTAR Medical

Main topics covered:

1 research methodology

2 research goals

3 research process

4 Scope and Coverage

4.1 Market Definition

4.2 Base Year

4.3 Scope of the Study

5 Report assumptions and reservations

5.1 Important caveats

5.2 Currency Conversion

5.3 Market Derivation

6 Market at a glance

7 Introduction

7.1 Overview

7.2 Effects of Covid-19

8 Market Opportunities and Trends

8.1 Rise of artificial intelligence to detect diabetic retinopathy

8.2 Use of artificial corneal implants

8.3 Increase in the use of robotic surgical assistants for eye surgeries

9 Market Growth Promoters

9.1 Increasing Advances in Ophthalmic Diagnostic Technology

9.2 Increasing acceptance of advanced eyepiece devices

9.3 Increase in the number of cases of eye diseases

9.4 Raising awareness of the diagnosis and treatment of eye diseases

9.5 Increase in preference for minimally invasive eye surgery

10 Market Restrictions

10.1 Strict Regulatory Approvals and Product Recalls

10.2 Increasing the risk of surgical failure

11 market landscape

11.1 Market Overview

11.2 Market Size and Forecast

11.3 Five Force Analysis

12 product

12.1 Market Overview and Growth Engine

12.2 Market Overview

12.3 Intraocular lenses

12.4 Glaucoma implants

12.5 Corneal Implants

12.6 Miscellaneous

13 application

13.1 Market overview and growth engine

13.2 Market Overview

13.3 Cataract surgery

13.4 Glaucoma Surgery

13.5 Miscellaneous

14 end users

14.1 Market overview and growth engine

14.2 Market Overview

14.3 Hospitals

14.4 Ambulatory Surgery Centers

14.5 Eye Clinics

15 geography

15.1 Market overview and growth engine

15.2 Geographical Overview

For more information about this report, visit

View source version on

Laura Wood, Senior Press Manager

For EST office hours, call 1-917-300-0470
For US/CAN call toll free 1-800-526-8630
For GMT office hours, call +353-1-416-8900

Leave a Comment